Hologic Inks Deal to Acquire Gen-Probe for $3.7B | GenomeWeb

NEW YORK (GenomeWeb News) – Hologic announced prior to market opening today that it will acquire Gen-Probe for approximately $3.7 billion, creating what company officials called the largest diagnostics company focused on women's health.

Terms of the all-cash transaction call for Hologic to acquire all outstanding shares of Gen-Probe for $82.75 per share, funded through available cash and additional financing.

Hologic said that it expects the deal to close in the second half of 2012, subject to approval by GenProbe's shareholders and other customary closing conditions.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.